Key Points
- Insider buying: David Blain purchased 158,965 shares of OptiBiotix Health at an average price of GBX 6, totaling about £9,537.90.
- Stock and valuation context: The shares opened at GBX 6.06, near the insider purchase price, with a 1-year range of GBX 4.50 to GBX 15 and a market cap of about £6.26 million.
- Recent financial results: OptiBiotix reported a quarterly EPS of GBX (3.84) and revenue of GBX 117 million, while posting negative margins and return on equity.
OptiBiotix Health Plc (LON:OPTI - Get Free Report) insider David Blain bought 158,965 shares of the company's stock in a transaction on Thursday, May 28th. The shares were acquired at an average price of GBX 6 per share, for a total transaction of £9,537.90.
OptiBiotix Health Price Performance
Shares of OptiBiotix Health stock opened at GBX 6.06 on Friday. OptiBiotix Health Plc has a 1 year low of GBX 4.50 and a 1 year high of GBX 15. The firm's 50-day moving average is GBX 5.31 and its two-hundred day moving average is GBX 6.35. The stock has a market cap of £6.26 million, a price-to-earnings ratio of -202.00 and a beta of 1.71.
OptiBiotix Health (LON:OPTI - Get Free Report) last issued its earnings results on Thursday, May 28th. The company reported GBX (3.84) earnings per share (EPS) for the quarter. OptiBiotix Health had a negative return on equity of 52.92% and a negative net margin of 333.62%.The business had revenue of GBX 117 million for the quarter.
OptiBiotix Health Company Profile
(
Get Free Report)
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
